Ottawa has a habit of producing quiet assassins in technology. Not loud, not flashy, just precise. Woodway Assurance fits that lineage perfectly. Founded in early fall 2025, this Canadian privacy technology company did not show up to make noise. It showed up to make proof. And in a world where data sharing goes to die in risk reviews, policy binders, and circular meetings, proof is the only thing that actually moves a decision forward.
Woodway Assurance just closed a USD $1M oversubscribed seed round announced December 17, 2025, led by Aventure Capital with participation from multiple angel investors. For a company already in market, already deployed, already generating revenue, this round feels less like speculation and more like formal validation. Frederic Boulanger and the team at Aventure Capital did not fund a slide deck. They funded momentum that was already earning its keep.
At the center is Dr. Khaled El Emam, Founder and CEO. Canada Research Chair Tier 1 in Medical AI at the University of Ottawa. Professor in the School of Epidemiology and Public Health. Senior Scientist at the Children’s Hospital of Eastern Ontario Research Institute. Director of the Electronic Health Information Laboratory. Multiple successful exits behind him, including Privacy Analytics and Replica Analytics. This is not academic cosplay. This is someone who has spent decades inside the hard, unglamorous problems of de-identification, synthetic data, and privacy assurance and knows exactly where organizations freeze.
That freeze is where EviData earns its name. Woodway Assurance’s flagship platform runs inside the client environment and automates privacy and utility assessment for de-identified and synthetic datasets. Re-identification risk analysis that used to take weeks and outside consultants now takes minutes. Auditable reports map directly to Canadian regulatory guidance and ISO standards. Governance teams stop defaulting to no and start issuing defensible yes decisions with evidence instead of anxiety.
The timing is not accidental. The global de-identified health data market was valued at USD $8.09B in 2024 and is projected to reach USD $13.59B by 2030 at a 9.07% CAGR. Healthcare providers are the fastest-growing consumers, driven by regulation and evidence-based decision making. North America already holds over 31.53% of global revenue. Woodway Assurance is building exactly where demand is not theoretical, it is mandatory.
The capital is going where disciplined companies put it. Sales and marketing to meet the market. Customer success to keep trust compounding. Continued enhancement of EviData to scale de-identification assurance across projects without slowing teams down. This is how infrastructure companies win. Quietly. Methodically. With receipts.
Aventure Capital said it plainly. Privacy assurance is becoming an essential layer in the modern data stack. Woodway Assurance is not asking organizations to believe. They are giving them evidence. In a data economy built on confidence, that may be the sharpest edge of all.
Startups Startup Funding Early Stage Venture Capital Seed Round Privacy Privacy Tech Data Data Driven Health Tech Healthcare Technology Innovation Tech Ecosystem Startup Ecosystem DCTalks
